test

Barbara Burtness MD

Clinical Research Program Leader, Head and Neck Cancers Program; Co-Director, Developmental Therapeutics Research Program; Professor of Medicine (Medical Oncology)

Biographical Info

Barbara Burtness, MD, has joined Medical Oncology at Yale Cancer Center, and will serve as Co-Leader of the Developmental Therapeutics Program and Clinical Research Program Leader for Head and Neck Cancer. Dr. Burtness is internationally recognized for her research in head and neck cancer. She chairs the Eastern Cooperative Oncology Group Head and Neck Cancer Committee, and leads national and international trials of targeted therapy in head and neck cancer. She comes to Yale from Fox Chase Cancer Center, where she co-led the Developmental Therapeutics Program and was Chief of Head and Neck Oncology.


Education & Training

AB
Bryn Mawr College (05/1982)
M.D.
SUNY at Stonybrook (1986)
Internship
Yale-New Haven Hospital, Internal Medicine  (1986 - 1987)
Residency
Yale-New Haven Hospital, Internal Medicine  (1987 - 1989)
Fellowship
Memorial Sloan Kettering Cancer Center, Medical Oncology  (1990 - 1993)
Board Certification
Internal Medicine, Board Certified  (1989)
Board Certification
Medical Oncology, Board Certified  (1993)

Honors & Recognition

  • Robert L. Krigel Award, Excellence in Teaching and Clinical Oncology
    Fox Chase Cancer Cener (2012)
  • Top Doctor
    U.S. News and World Report 
  • Best Doctors in America
    Best Doctors 

Professional Service

  • ECOG-ACRIN (5/1/2006 - 04/30/2019)

Edit Profile